BETA DRUGS
Back to Cashflow Statement
|
BETA DRUGS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹118 Cr | ₹-7.49 Cr | ₹-2.47 Cr | ₹-0.97 Cr | ₹-7.71 Cr |
What is the latest Cash Flow from Financing Activities ratio of BETA DRUGS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹118 Cr |
| Mar2024 | ₹-7.49 Cr |
| Mar2023 | ₹-2.47 Cr |
| Mar2022 | ₹-0.97 Cr |
| Mar2021 | ₹-7.71 Cr |
How is Cash Flow from Financing Activities of BETA DRUGS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹118 Cr | Positive | |
| Mar2024 | ₹-7.49 Cr | Negative | |
| Mar2023 | ₹-2.47 Cr | Negative | |
| Mar2022 | ₹-0.97 Cr | Negative | |
| Mar2021 | ₹-7.71 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,634.8 Cr | 0.9% | 8.4% | 45% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | 0.9% |
8.4% |
45% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses